Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma von Loriot, Yohann, Necchi, Andrea, Park, Se Hoon, Garcia-Donas, Jesus, Huddart, Robert, Burgess, Earle, Fleming, Mark, Rezazadeh, Arash, Mellado, Begoña, Varlamov, Sergey, Joshi, Monika, Duran, Ignacio, Tagawa, Scott T, Zakharia, Yousef, Zhong, Bob, Stuyckens, Kim, Santiago-Walker, Ademi, De Porre, Peter, O’Hagan, Anne, Avadhani, Anjali, Siefker-Radtke, Arlene O

Volltext

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics von Borcherding, Nicholas, Vishwakarma, Ajaykumar, Voigt, Andrew P., Bellizzi, Andrew, Kaplan, Jacob, Nepple, Kenneth, Salem, Aliasger K., Jenkins, Russell W., Zakharia, Yousef, Zhang, Weizhou

Volltext

Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond von Muller, Alexander J., Manfredi, Mark G., Zakharia, Yousef, Prendergast, George C.

Volltext

Antibody Drug Conjugates in Bladder Cancer: Current Milestones and Future Perspectives von Alameddine, Raafat, Mallea, Patrick, Shahab, Farhan, Zakharia, Yousef

Volltext

Potential Role of Selenium in the Treatment of Cancer and Viral Infections von Rataan, Aseel O, Geary, Sean M, Zakharia, Yousef, Rustum, Youcef M, Salem, Aliasger K

Volltext

Detection of pro angiogenic and inflammatory biomarkers in patients with CKD von Jalal, Diana, Sanford, Bridget, Renner, Brandon, Ten Eyck, Patrick, Laskowski, Jennifer, Cooper, James, Sun, Mingyao, Zakharia, Yousef, Spitz, Douglas, Dokun, Ayotunde, Attanasio, Massimo, Jones, Kenneth, Thurman, Joshua M.

Volltext

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma von Garje, Rohan, An, Josiah, Greco, Austin, Vaddepally, Raju Kumar, Zakharia, Yousef

Volltext

Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003 von Dudek, Arkadiusz Z., Liu, Li C., Gupta, Shilpa, Logan, Theodore F., Singer, Eric A., Joshi, Monika, Zakharia, Yousef N., Lang, Joshua M., Schwarz, James K., Al-Janadi, Anas, Alva, Ajjai S.

Volltext

CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells von Kim, Myung-Chul, Borcherding, Nicholas, Ahmed, Kawther K., Voigt, Andrew P., Vishwakarma, Ajaykumar, Kolb, Ryan, Kluz, Paige N., Pandey, Gaurav, De, Umasankar, Drashansky, Theodore, Helm, Eric Y., Zhang, Xin, Gibson-Corley, Katherine N., Klesney-Tait, Julia, Zhu, Yuwen, Lu, Jinglu, Lu, Jinsong, Huang, Xian, Xiang, Hongrui, Cheng, Jinke, Wang, Dongyang, Wang, Zheng, Tang, Jian, Hu, Jiajia, Wang, Zhengting, Liu, Hua, Li, Mingjia, Zhuang, Haoyang, Avram, Dorina, Zhou, Daohong, Bacher, Rhonda, Zheng, Song Guo, Wu, Xuefeng, Zakharia, Yousef, Zhang, Weizhou

Volltext

PARP Inhibitors in Prostate and Urothelial Cancers von Garje, Rohan, Vaddepally, Raju Kumar, Zakharia, Yousef

Volltext

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer von Fox, Eric, Oliver, Thomas, Rowe, Melissa, Thomas, Sunil, Zakharia, Yousef, Gilman, Paul B, Muller, Alexander J, Prendergast, George C

Volltext

Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043 von Zakharia, Yousef, Singer, Eric A., Acharyya, Satwik, Garje, Rohan, Joshi, Monika, Peace, David, Baladandayuthapani, Veera, Majumdar, Annesha, Li, Xiong, Lalancette, Claudia, Kryczek, Ilona, Zou, Weiping, Alva, Ajjai

Volltext

Identification of blood lipid markers of docetaxel treatment in prostate cancer patients von Finnerty, Morgan C., Leach, Franklin E., Zakharia, Yousef, Nepple, Kenneth G., Bartlett, Michael G., Henry, Michael D., Cummings, Brian S.

Volltext

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment von Garje, Rohan, An, Josiah J, Sanchez, Kevin, Greco, Austin, Stolwijk, Jeffrey, Devor, Eric, Rustum, Youcef, Zakharia, Yousef

Volltext

Understanding the Redox Biology of Selenium in the Search of Targeted Cancer Therapies von Stolwijk, Jeffrey M., Garje, Rohan, Sieren, Jessica C., Buettner, Garry R., Zakharia, Yousef

Volltext

Real-World Therapy Management and Outcomes of First-Line Axitinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma in the United States von Zakharia, Yousef, Thomaidou, Despina, Li, Benjamin, Siu, Gordon, Levin, Rebecca, Vlahiotis, Anna, Rao, Dharanija, Zanotti, Giovanni

Volltext

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets von Swearson, Samuel, Rataan, Aseel O, Eliason, Steven, Amendt, Brad A, Zakharia, Yousef, Salem, Aliasger K, Ho, Thai, Rustum, Youcef M

Volltext

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma von Zakharia, Yousef, McWilliams, Robert R, Rixe, Olivier, Drabick, Joseph, Shaheen, Montaser F, Grossmann, Kenneth F, Kolhe, Ravindra, Pacholczyk, Rafal, Sadek, Ramses, Tennant, Lucinda L, Smith, Christopher M, Kennedy, Eugene P, Link Jr, Charles J, Vahanian, Nicholas N, Yu, Jiayi, Shen, Steven S, Brincks, Erik L, Rossi, Gabriela R, Munn, David, Milhem, Mohammed

Volltext

Obesity diminishes response to PD-1-based immunotherapies in renal cancer von Boi, Shannon K, Orlandella, Rachael M, Gibson, Justin Tyler, Turbitt, William James, Wald, Gal, Thomas, Lewis, Buchta Rosean, Claire, Norris, Katlyn E, Bing, Megan, Bertrand, Laura, Gross, Brett P, Makkouk, Amani, Starenki, Dmytro, Farag, Kristine I, Sorge, Robert E, Brown, James A, Gordetsky, Jennifer, Yasin, Hesham, Garje, Rohan, Nandagopal, Lakshminarayanan, Weiner, George J, Lubaroff, David M, Arend, Rebecca C, Li, Peng, Zakharia, Yousef, Yang, Eddy, Salem, Aliasger K, Nepple, Kenneth, Marquez-Lago, Tatiana T, Norian, Lyse A

Volltext

Management of Renal Cell Carcinoma With Supradiaphragmatic Inferior Vena Cava Thrombus Diagnosed During Acute COVID-19 Infection von Leyderman, Michael, McElree, Ian M, Nepple, Kenneth G, Zakharia, Yousef, Ghodoussipour, Saum, Packiam, Vignesh T

Volltext